Home

Cash

Spendthrift Wife? Here's How to Control Her

Wed, 19/01/2011 - 16:08 by Gauri Retarekar

Money conflicts are common to all households. But if your wife is splurging your hard earned money on things that you don’t even require, perhaps its time you draw the line.

Money Pledges for 2011

Sat, 08/01/2011 - 11:13 by Gunjan Mehra

Even small changes in your money behavior can help you attain a better financial position. The Money Times suggests some money resolutions, capable of changing your money status this year.

Is GameStop the Perfect Stock?

Sat, 01/01/2011 - 10:38 by Dan Caplinger

 Everyone would love to find the perfect stock. But will you ever really find a stock that gives you everythingyou could possibly want? One thing's for sure: If you don't look, you'll never find truly great investments. So let's first take a look at what you'd want to see from a perfect stock, and then decide if GameStop(NYSE: GME) fits the bill.

 

Is Ford's Momentum Stalling?

Sat, 01/01/2011 - 10:35 by John Rosevear

 How did your favorite automaker do in 2010? We'll know for sure when the year's final sales numbers are released next week. But some trends have been clear for a while: Ford (NYSE: F) is going gangbusters, General Motors(NYSE: GM) is showing signs of strength, Honda (NYSE:HMC) is holding its ground despite some product challenges, and Toyota (NYSE: TM) ... well, Toyota had a year to forget.

 

5-Star Stocks Poised to Pop: Ormat Technologies

Fri, 31/12/2010 - 14:46 by Brian D. Pacampara

Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, geothermal power plant operator Ormat Technologies (NYSE: ORA) has earned a coveted five-star ranking.

5-Star Stocks Poised to Pop: U.S. Ecology

Thu, 30/12/2010 - 11:58 by Brian D. Pacampara

Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, hazardous waste disposal specialist U.S. Ecology (Nasdaq: ECOL) has earned a coveted five-star ranking.

Is Medtronic the Perfect Stock?

Wed, 29/12/2010 - 12:24 by Dan Caplinger

Everyone would love to find the perfect stock. But will you ever really find a stock that gives you everythingyou could possibly want? One thing's for sure: If you don't look, you'll never find truly great investments. So let's first take a look at what you'd want to see from a perfect stock, and then decide if Medtronic(NYSE: MDT) fits the bill.

The Optimist's Guide to 2011

Wed, 29/12/2010 - 10:29 by Morgan Housel

Things tend to get better over time. That's just the way it works. Life expectancy, real income, technology, medicine, transportation, communication ... these things tend to rise relentlessly higher for the majority of the world over time, pushing aside wars, famines, recessions, and natural disasters that get in their way.

5-Star Stocks Poised to Pop: Agrium

Wed, 29/12/2010 - 09:57 by Brian D. Pacampara

Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, fertilizer producer Agrium (NYSE: AGU) has earned a coveted five-star ranking.

4-Star Stocks Poised to Pop: BorgWarner

Wed, 29/12/2010 - 09:49 by Brian D. Pacampara

Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, auto supplier BorgWarner (NYSE: BWA) earned a respected four-star ranking.

5-Star Stocks Poised to Pop: Trident Microsystems

Tue, 28/12/2010 - 06:56 by Brian D. Pacampara

 Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, home entertainment chip specialist Trident Microsystems (Nasdaq: TRID) has earned a coveted five-star ranking.

 

4-Star Stocks Poised to Pop: Bristol-Myers

Tue, 28/12/2010 - 06:45 by Brian D. Pacampara

 Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmaceutical giant Bristol-Myers Squibb(NYSE: BMY) has earned a respected four-star ranking.